title: Large cell/anaplastic medulloblastomas and medullomyoblastomas: clinicopathological and genetic features.
abstract: OBJECTIVE
  Medulloblastoma is the most common malignant central nervous system neoplasm found in children. A distinct variant designated large cell/anaplastic (LC/A) medulloblastoma is characterized by frequent dissemination of cerebrospinal fluid (CSF) at presentation and a more aggressive clinical course. The authors report on their examination of the clinicopathological and genetic features of seven such cases encountered at their institution.
  
  
  METHODS
  Eighty cases of medulloblastomas were reviewed and seven (8.8%) of these were believed to fit the histological and immunohistochemical criteria for LC/A medulloblastoma. In three cases (43%) either desmoplastic or classic medulloblastoma was the underlying subtype, and in two cases (28%) the LC/A tumor was found within the setting of medullomyoblastoma. Fluorescence in situ hybridization was used in six of the seven cases to characterize the presence of isochromosome 17q, deletion of chromosome 22q (a deletion characteristically found in atypical teratoid/rhabdoid tumors), and c-myc amplification. The patients' clinical histories revealed CSF dissemination in all cases and lymph node metastasis in one case. Isochromosome 17q was found in five (83%) of six cases. Evidence of chromosomal gains indicated aneuploidy in three tumors (50%), and amplification of c-myc was found in three tumors (50%). No 22q deletions were encountered.
  
  
  CONCLUSIONS
  A high percentage of LC/A medulloblastomas arise within a background of typical medulloblastomas or medullomyoblastomas. As is the case in conventional medulloblastomas, the presence of 17q is a common early tumorigenic event; however, in a significant percentage of specimens there is also evidence of aneuploidy and/or amplification of c-myc. These findings indicate that LC/A morphological characteristics reflect a more advanced tumor stage than that found in pure medulloblastomas or in typical medullomyoblastomas.
authors.affiliation: Department of Neurosurgery, Washington University School of Medicine, St. Louis Children's Hospital, Missouri 63110, USA.
authors.forename: J R
authors.initials: JR
authors.lastname: Leonard
authors.forename: D X
authors.initials: DX
authors.lastname: Cai
authors.forename: D J
authors.initials: DJ
authors.lastname: Rivet
authors.forename: B A
authors.initials: BA
authors.lastname: Kaufman
authors.forename: T S
authors.initials: TS
authors.lastname: Park
authors.forename: B K
authors.initials: BK
authors.lastname: Levy
authors.forename: A
authors.initials: A
authors.lastname: Perry
mesh_terms: D000293:Adolescent; D000328:Adult; D000782:Aneuploidy; D014408:Biomarkers, Tumor / Q000235:genetics*; D002528:Cerebellar Neoplasms / Q000235:genetics / Q000473:pathology* / Q000601:surgery; D002531:Cerebellum / Q000473:pathology / Q000601:surgery; D002648:Child; D002869:Chromosome Aberrations; D002872:Chromosome Deletion; D002874:Chromosome Mapping; D002892:Chromosomes, Human, Pair 22; D005260:Female; D015972:Gene Expression Regulation, Neoplastic / Q000502:physiology; D006801:Humans; D017404:In Situ Hybridization, Fluorescence; D008527:Medulloblastoma / Q000235:genetics / Q000473:pathology* / Q000601:surgery; D011379:Prognosis; D016271:Proto-Oncogene Proteins c-myc / Q000235:genetics
chemical_list: D014408:Biomarkers, Tumor; C489427:MYC protein, human; D016271:Proto-Oncogene Proteins c-myc